Virchows Archiv

, Volume 456, Issue 5, pp 483–490 | Cite as

Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases

  • Matthias Choschzick
  • Linn Woelber
  • Stephan Hess
  • Christine zu Eulenburg
  • Jörg Schwarz
  • Ronald Simon
  • Sven Mahner
  • Fritz Jaenicke
  • Volkmar Müller
Original Article

Abstract

Carbonic anhydrase IX (CAIX) is a strictly membranous expressed metalloenzyme involved in cell adhesion, pH homeostasis, and cancer progression. The protein is specifically overexpressed in a wide variety of malignant tumors. This study was designed to assess the role of CAIX in primary vulvar cancer. One hundred forty-two well-characterized primary vulvar carcinomas were analyzed on a tissue microarray (TMA). Three tissue cores were sampled from each tumor. CAIX expression was determined by immunohistochemistry, using a four-step scoring system. To determine CAIX expression in benign vulvar tissue, we constructed a TMA with 120 samples of normal mucosa and non-neoplastic diseases. CAIX expression was found in 77/135 (57%) of all assessable vulvar cancer specimens and 48 (35.5%) exhibited a moderate or strong expression. CAIX expression in vulvar carcinomas was significantly stronger compared to non-neoplastic vulvar tissue (p < 0.001). High levels of CAIX expression were related to pT stage (p < 0.01), tumor size (p < 0.01), depth of invasion (p < 0.05), as well as inguinal lymph node metastases (p < 0.05). There was also a trend towards shorter recurrence-free patient survival in CAIX-positive compared to CAIX-negative vulvar cancers. CAIX staining results in different tissue cores from the same tumor were homogeneous, raising the possibility of a hypoxia-independent expression. In conclusion, CAIX is overexpressed in the majority of vulvar carcinomas with relationships to advanced tumor stages and development of lymph node metastases. Our data support the potential therapeutic benefit of newly developed targeting antibodies in advanced vulvar cancer.

Keywords

Carbonic anhydrase Vulvar cancer Metastasis Prognosis 

Notes

Conflict of interest statement

We declare that we have no conflict of interest.

References

  1. 1.
    Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033CrossRefPubMedGoogle Scholar
  2. 2.
    Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 18:330–337CrossRefPubMedGoogle Scholar
  3. 3.
    Potter CP, Harris AL (2003) Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 89:2–7CrossRefPubMedGoogle Scholar
  4. 4.
    Winum JY, Poulsen SA, Supuran CT (2009) Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 29:419–435CrossRefPubMedGoogle Scholar
  5. 5.
    Zavada J, Zavadova Z, Pastorekova S et al (1993) Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268–274CrossRefPubMedGoogle Scholar
  6. 6.
    Potter C, Harris Al (2004) Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3:164–167PubMedGoogle Scholar
  7. 7.
    Robertson N, Potter C, Harris AL (2004) Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 64:6160–6165CrossRefPubMedGoogle Scholar
  8. 8.
    Kaluz S, Kaluzova M, Liao SY et al (2009) Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochim Biophys Acta 1795:162–172PubMedGoogle Scholar
  9. 9.
    Ivanov S, Liao SY, Ivanova A et al (2001) Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158:905–919PubMedGoogle Scholar
  10. 10.
    Hussain SA, Ganesan R, Reynolds G et al (2007) Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer 96:104–109CrossRefPubMedGoogle Scholar
  11. 11.
    Klatte T, Seligson DB, Rao JY (2009) Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Cancer 115:1448–1458CrossRefPubMedGoogle Scholar
  12. 12.
    Loncaster JA, Harris AL, Davidson SE et al (2001) Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394–6399PubMedGoogle Scholar
  13. 13.
    Swinson DE, Jones JL, Richardson D (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21:473–482CrossRefPubMedGoogle Scholar
  14. 14.
    Simon R, Mirlacher M, Sauter G (2004) Tissue microarrays. Biotechniques 36:98–105PubMedGoogle Scholar
  15. 15.
    Petersen I, Schewe C, Schluns K et al (2007) Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Arch 451:701–716CrossRefPubMedGoogle Scholar
  16. 16.
    Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMedGoogle Scholar
  17. 17.
    Woelber L, Mahner S, Voelker K et al (2009) Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 29:545–552PubMedGoogle Scholar
  18. 18.
    Lee WY, Huang SC, Hsu KF et al (2008) Roles for hypoxia-regulated genes during cervical carcinogenesis: somatic evolution during the hypoxia-glycolysis-acidosis sequence. Gynecol Oncol 108:377–384CrossRefPubMedGoogle Scholar
  19. 19.
    Choi SW, Kim JY, Park JY et al (2008) Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Hum Pathol 39:1317–1322CrossRefPubMedGoogle Scholar
  20. 20.
    Tanaka N, Kato H, Inose T et al (2008) Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer 99:1468–1475CrossRefPubMedGoogle Scholar
  21. 21.
    Bubendorf L, Nocito A, Moch H et al (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195:72–79CrossRefPubMedGoogle Scholar
  22. 22.
    Ruiz C, Seibt S, Al Kuraya K (2006) Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int J Cancer 118:2190–2194CrossRefPubMedGoogle Scholar
  23. 23.
    Torhorst J, Bucher C, Kononen J et al (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249–2256PubMedGoogle Scholar
  24. 24.
    Fons G, Hasibuan SM, van der Velden J et al (2007) Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol 60:500–503CrossRefPubMedGoogle Scholar
  25. 25.
    Gulmann C, Butler D, Kay E et al (2003) Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 42:70–76CrossRefPubMedGoogle Scholar
  26. 26.
    Rubin MA, Dunn R, Strawderman M et al (2002) Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 26:312–319CrossRefPubMedGoogle Scholar
  27. 27.
    Fons G, van der Velden J, Burger M et al (2009) Validation of tissue microarray technology in vulvar cancer. Int J Gynecol Pathol 28:76–82CrossRefPubMedGoogle Scholar
  28. 28.
    Ruan K, Song G, Ouyang G (2009) Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107:1053–1062CrossRefPubMedGoogle Scholar
  29. 29.
    Kaluz S, Kaluzova M, Chrastina A et al (2002) Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Res 62:4469–4477PubMedGoogle Scholar
  30. 30.
    Kopacek J, Barathova M, Dequiedt F et al (2005) MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Biochim Biophys Acta 1729:41–49PubMedGoogle Scholar
  31. 31.
    Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8:705–713CrossRefPubMedGoogle Scholar
  32. 32.
    Kong CS (2009) The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 74:553–561PubMedGoogle Scholar
  33. 33.
    Resnick M (1996) Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. Hum Pathol 27:234–239CrossRefPubMedGoogle Scholar
  34. 34.
    Wykoff CC, Beasley N, Watson PH et al (2001) Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 158:1011–1019PubMedGoogle Scholar
  35. 35.
    Drew PA, al-Abbadi MA, Orlando CA (1996) Prognostic factors in carcinoma of the vulva: a clinicopathologic and DNA flow cytometric study. Int J Gynecol Pathol 15:235–241PubMedCrossRefGoogle Scholar
  36. 36.
    Svastova E, Hulikova A, Rafajova M et al (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577:439–445CrossRefPubMedGoogle Scholar
  37. 37.
    Swietach P, Patiar S, Supuran CT et al (2009) The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in 3-D tumor-cell growths. J Biol Chem 284:20299–20310CrossRefPubMedGoogle Scholar
  38. 38.
    Mulders P, Bleumer I, Debruyne F, et al. (2004) Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IX(G250/MN) Urologe A 43 Suppl 3:S146-147: 146-147Google Scholar
  39. 39.
    Bauer S, Oosterwijk-Wakka JC, Adrian N et al (2009) Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. Int J Cancer 125:115–123CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Matthias Choschzick
    • 1
    • 4
  • Linn Woelber
    • 2
  • Stephan Hess
    • 1
  • Christine zu Eulenburg
    • 3
  • Jörg Schwarz
    • 2
    • 5
  • Ronald Simon
    • 1
  • Sven Mahner
    • 2
  • Fritz Jaenicke
    • 2
  • Volkmar Müller
    • 2
  1. 1.Institute of PathologyUniversity Medical Centre Hamburg-EppendorfHamburgGermany
  2. 2.Department of GynecologyUniversity Medical Centre Hamburg-EppendorfHamburgGermany
  3. 3.Department of Medical Biometry and EpidemiologyUniversity Medical Centre Hamburg-EppendorfHamburgGermany
  4. 4.Department of PathologyUniversity Medical Centre Hamburg-EppendorfHamburgGermany
  5. 5.Department of GynecologyAsklepios Clinic NordHamburgGermany

Personalised recommendations